Current and emerging osteoporosis pharmacotherapy for women: state of the art therapies for preventing bone loss.

Fontalis, A. orcid.org/0000-0001-5547-288X, Kenanidis, E., Kotronias, R.A. et al. (4 more authors) (2019) Current and emerging osteoporosis pharmacotherapy for women: state of the art therapies for preventing bone loss. Expert Opinion on Pharmacotherapy. ISSN 1465-6566

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2019 Taylor & Francis. This is an author-produced version of a paper subsequently published in Expert Opinion on Pharmacotherapy. Uploaded in accordance with the publisher's self-archiving policy.
Keywords: Osteoporosis; abaloparatide; antiresorptive medications; osteoanabolic agents; romosozumab; sclerostin
Dates:
  • Accepted: 11 March 2019
  • Published (online): 8 April 2019
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > Department of Oncology (Sheffield)
Depositing User: Symplectic Sheffield
Date Deposited: 15 Apr 2019 13:50
Last Modified: 15 Apr 2019 13:50
Status: Published online
Publisher: Taylor & Francis
Refereed: Yes
Identification Number: https://doi.org/10.1080/14656566.2019.1594772
Related URLs:

Download

Accepted Version


Embargoed until: 8 April 2020

Filename: EOOP Manuscript.pdf

Request a copy

Share / Export

Statistics